Business Standard

Global law firms discuss lockdown compensation suits, India too at risk

Lawyers agree that at present the probability of such a suit arising is very low, but not unlikely

gavel, Insolvency, IBC, firms
Premium

In India, the export of 26 active pharmaceutical ingredients and issuing compulsory licenses for drugs made by foreign pharmaceutical companies, are examples of such measures

Namrata Acharya Kolkata
Two Europe-based non-government research firms--Corporate Europe Observatory (CEO) and the Transnational Institute (TNI)--have raised red flags over potential law suits against governments by foreign investors who suffered losses due to measures taken during lockdownn on account of Covid-19. In a research article called <Cashing in on the pandemic: how lawyers are preparing to sue states over Covid-19 response measures>, it has been pointed out that the legal industry is preparing the ground for costly ISDS (investor-state dispute settlement) suits against governments.

Some of the bilateral trade and investment treaties signed by governments give sweeping powers to foreign investors, including the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in